Kazazian Asset Management’s bluebird bio BLUE Stock Holding History

Kazazian Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$258K	Hold	217	–	–	0.35%	40
2019 Q2	$357K	Sell	217 -28	-11%	-$48.4K	0.42%	42
2019 Q1	$500K	Sell	245 -56	-19%	-$98.6K	0.69%	32
2018 Q4	$387K	Sell	301 -183	-38%	-$281K	0.52%	34
2018 Q3	$915K	Buy	484 +145	+43%	+$300K	0.86%	30
2018 Q2	$688K	Sell	339 -13	-4%	-$29.6K	0.63%	37
2018 Q1	$778K	Hold	352	–	–	0.82%	32
2017 Q4	$811K	Buy	352 +37	+12%	+$75.1K	0.83%	30
2017 Q3	$561K	Buy	315 +130	+70%	+$182K	0.69%	32
2017 Q2	$252K	Sell	185 -54	-23%	-$65.2K	0.38%	43
2017 Q1	$282K	Sell	239 -193	-45%	-$197K	0.39%	33
2016 Q4	$346K	Buy	+432	New	+$343K	0.48%	27

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Kazazian Asset Management's BLUE Position: Q3 2019 in Review

Kazazian Asset Management held its bluebird bio (BLUE) position steady in Q3 2019 at 217 shares worth $258K. The position accounts for 0.35% of the portfolio, ranked #40.

Kazazian Asset Management first reported a position in BLUE in Q4 2016 and has held it in 12 quarters since. The position peaked at $915K in Q3 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

Kazazian Asset Management held 217 shares of bluebird bio worth $258K as of Q3 2019.
Kazazian Asset Management left its bluebird bio share count unchanged in Q3 2019.
bluebird bio made up 0.35% of Kazazian Asset Management's portfolio in Q3 2019, its #40 holding.
Kazazian Asset Management first reported a position in bluebird bio in Q4 2016 and has held it in 12 quarters since.
Kazazian Asset Management's bluebird bio position peaked at $915K in Q3 2018.
241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Kazazian Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.